Innovation & Research
The participation in publicly funded research projects allows us to contribute to the investigation and development of novel technological approaches to deliver small volumes of liquids of any kind and any rheology. Our scientific background in combination with our engineering expertise result in precise and reliable solutions, driving the low volume dispensing market to unprecedented possibilities.
The 3D Bio-Net is a collaboration project to establish an advanced 3D Bio-Printing platform in the network of small and medium-sized enterprises (KMU).
As part of the overall project, Biofluidix is engaged in the research of dosing technologies for 3D bio-printing and the realization of a 3D-BioPrinter with sterilizable dosing components. The aim of the sub-project is to provide a device that is equipped with innovative, sterilizable dosing technology based on disposable components and can be used for the research work of the partners. At the end of the project, a functional, experimentally characterized demonstrator with associated 3D bio-printing processes will be presented to the public.
Bio-printable 3D in vitro tumor-tissue-model for high throughput testing of tumor therapeutics.
The number of cancer patients is increasing steadily. This fact expresses the urgent need of understanding the origin of tumors and drives the development of novel treatment methods. Since the development of new tumor-therapeutic substances is highly time-consuming and costly, an affordable alternative is desired for the future. This can be achieved by earlier identification of relevant drug candidates and better prediction of their efficacy. Therefore, it is necessary to use a suitable in vitro substitute, like a 3D-tumor-tissue model, for an early testing. The aim of the project 3D TuMoPrint is to establish a high-throughput testing system for tumor therapeutics based on a 3D-organotypic-tumor-tissue model in biomimetic hydrogels for the production in a bio-printer workstation. Apart from the model production, the system should have an integrated microscopic control to simplify the analysis of the models.
15.01.2019 - 15.01.2021
HFU, Campus Schwenningen, Pelobiotech GmbH
Baden Württemberg - Ministerium für Wissenschaft Forschung und Kunst
Digital immuno-isothermal nucleic acid amplification (dINA) assay for high-sensitivity analyzes with a wide dynamic range.
The goal is to use the dINA project to replace existing technologies (ELISA etc.) for the precise quantification of active substances and to establish a new technology platform for highly sensitive analytical methods. Compared to existing methods, it represents a significant system simplification exceeding the current state of the art technologies in terms of precision of quantification as well as speed and cost-effectiveness. Therefore, the aim of this project is to realize and characterize a functional model of a centrifugal processing device, which is suitable for the automated performance of biochemical analyzes based on so-called "digital amplification processes" in emulsion.